N-(tert-Butoxycarbonyl)glycylglycine, catalogue identifier Boc-Gly-Gly-OH, is supplied as an amino-terminal protected dipeptide for solution-phase peptide assembly. The compound carries tert-butoxycarbonyl protection on the glycine amine and retains a free carboxyl group at the glycine C-terminus, allowing direct activation without a preliminary deprotection step. The molecular formula C9H16N2O5 corresponds to a formula weight of 232.23 g/mol, and the CAS registry number is 1482-70-8. Representative catalogue pack designations include BGG-100-25, BGG-100-100, and BGG-100-500, where the trailing numeral indicates net fill weight in grams; because no harmonised model system exists across suppliers, the CAS number functions as the invariant lot-to-lot identifier. Routine material is a white to off-white crystalline powder with a typical melting range of 118–121 °C, although melting behaviour may be accompanied by decomposition at slower heating rates. The compound is structurally achiral because both amino acid residues are glycine; therefore specific rotation is not a meaningful release parameter. Qualitative solubility places the substance in high solubility in DMF and DMSO, moderate solubility in methanol and ethyl acetate, and sparing aqueous solubility. The free carboxyl permits activation as an acyl chloride, mixed anhydride, active ester, or carbodiimide/Oxyma species, while the Boc group remains stable to the basic coupling environment.

What Release Specifications and Analytical Methods Apply to Boc-Gly-Gly-OH Lot Acceptance?

Lot acceptance for Boc-Gly-Gly-OH is generally controlled against a set of chromatographic, thermal, and gravimetric criteria. Because supplier-specific release profiles differ, the following table consolidates the typical acceptance limits appearing in manufacturer certificates of analysis for research-grade and peptide-synthesis grades. Each value should be revalidated against the lot-specific CoA, as trace residual solvents may shift according to crystallisation and drying conditions.

HPLC purity is typically determined using a C18 reversed-phase column under gradient elution with acetonitrile/water containing 0.1% trifluoroacetic acid or 0.05% formic acid, with UV detection at 214 nm and 220 nm. The absence of UV-chromophoric side chains in glycine makes low-wavelength detection necessary, which can exaggerate baseline disturbances from solvent impurities; therefore mobile phase purity and column temperature control at 25–30 °C are critical for reproducible integration. Identity is normally confirmed by electrospray ionisation mass spectrometry, with the protonated molecular ion [M+H]⁺ expected at m/z 233.1, and by infrared comparison against a certified reference spectrum. Published data for exact response factors of trace related substances in this configuration are limited; single-point area normalisation is therefore used for routine release, but it should not be interpreted as an absolute mass balance.

Residual solvent analysis for this dipeptide is particularly relevant because the final crystallisation from ethyl acetate, dichloromethane, or methyl tert-butyl ether can leave traces that interfere with sensitive NMR or cell-based assays. Suppliers characterising material for GMP peptide synthesis commonly test for dichloromethane, methanol, ethyl acetate, and tert-butanol using headspace gas chromatography according to USP <467>. The ICH Q3C Option 2 limit for dichloromethane is 600 ppm, for methanol 3000 ppm, and for tert-butanol 5000 ppm; actual lot values are often lower but must be verified when the dipeptide is used at high stoichiometric excess. In process development, poorly dried material with water above 0.5% can reduce carbodiimide activation efficiency by hydrolysing O-acylisourea intermediates, leading to a free acid that fails to acylate the resin or solution-phase amine.

Because the tert-butoxycarbonyl group is slowly hydrolysed by water and more rapidly cleaved by strong acid, storage and handling are dominated by protection of the N-terminal masking group. The product is routinely stored at 2–8 °C in tightly closed containers under desiccant; for storage beyond 12 months, aliquots may be held at -20 °C under argon to slow hydrolytic degradation. Containers should be warmed to room temperature before opening to avoid condensation on the powder surface, and any large-scale dispensing should occur under a dry nitrogen sweep when relative humidity exceeds 60%. The substance is incompatible with concentrated hydrochloric acid, trifluoroacetic acid, and anhydrous hydrogen chloride, all of which remove the Boc group; it is also incompatible with strong aqueous alkali, which can saponify the terminal carboxyl and promote hydration. During pilot-plant handling, batch-to-batch variability in residual tert-butanol has been observed when solvent-drying cycles are shortened; if the downstream coupling step is sensitive to alcohol content, the lot-specific residual solvents report should be checked before charging the reactor.

For bulk reactor charging, the powder is generally dissolved in the reaction solvent before addition of base or coupling reagent. Pre-dissolution in DMF at 50–100 g/L is typical for pilot-scale peptide couplings, but the solution should be used within 2 h if stored at ambient temperature because slow N-acyl urea build-up can occur after activation, not before. Agitation should be gentle; high-shear dispersion in DMF is unnecessary because the compound is soluble in the reaction medium. When a slurry is observed, this typically indicates water uptake or storage at low temperature; the slurry should not be heated above 40 °C to force dissolution, because thermolytic cleavage of the Boc group accelerates sharply above that temperature in the presence of residual acid. Instead, fresh anhydrous solvent should be used and the container returned to desiccated storage.

Structural and Reactivity Distinctions Against Adjacent Glycine Building Blocks

Compared with Boc-Gly-OH, Boc-Gly-Gly-OH introduces an additional glycine residue, raising the formula weight from 175.18 g/mol to 232.23 g/mol and changing the carboxyl activation species from a single-residue acyl donor to a dipeptide acyl donor. This difference is material when the target sequence contains consecutive glycine residues: a single coupling with the dipeptide avoids one complete activation, washing, and deprotection cycle, reducing opportunities for diketopiperazine formation and improving mass balance in linear solid-phase synthesis. Compared with H-Gly-Gly-OH, the Boc-protected derivative eliminates free amino nucleophilicity at the N-terminus and permits carbodiimide-mediated activation without competing amine-side reactions. The unprotected dipeptide is a zwitterion with limited solubility in nonpolar coupling solvents, whereas Boc-Gly-Gly-OH dissolves readily in DMF and DCM under normal activation conditions.

Relative to Fmoc-Gly-Gly-OH, the Boc derivative is cleaved by acid rather than by piperidine or 4-methylpiperidine in DMF; this makes Boc-Gly-Gly-OH the preferred variant when the assembled intermediate must survive repeated Fmoc deprotection cycles. The Fmoc analogue is selected when the final peptide requires acid-stable side-chain protecting groups, because TFA-based Boc cleavage would also remove Boc, t-Bu, and trityl groups. Cbz-Gly-Gly-OH, in contrast, is removed under hydrogenolysis or HBr in acetic acid and therefore provides an orthogonal N-protection strategy when both acid-labile and base-labile groups are already present. The table below summarises the structural and operational distinctions for adjacent building blocks. Molecular weights and CAS numbers are compiled from supplier catalogue values; confirm lot-specific certificates before fill-and-finish.

The risk of diketopiperazine formation is a central distinction when comparing dipeptide building blocks. H-Gly-Gly-OH and its esters can cyclise to 2,5-piperazinedione under neutral or basic conditions, especially during prolonged storage or coupling at elevated pH. Boc-Gly-Gly-OH has the glycine amine masked, so diketopiperazine formation cannot proceed until the Boc group is removed; once deprotection occurs, the free amino terminus can attack the C-terminal ester or activated carboxyl in a six-membered cyclisation. This is why final peptide assembly using Boc-Gly-Gly-OH should avoid long delays between Boc removal and the next coupling step, particularly in solution-phase routes where the free amine intermediate is not immobilised on a resin. The same behaviour is exploited deliberately in some piperazinedione syntheses, but in peptide build-up it is a failure mode.

In solution-phase glycine peptide assembly, Boc-Gly-Gly-OH is activated as the carboxyl component under standard carbodiimide or uronium salt conditions. A typical coupling is conducted in anhydrous DMF or dichloromethane at 0–4 °C during activation, followed by slow warming to 20–25 °C. Coupling reagents include N,N'-diisopropylcarbodiimide with ethyl cyano(hydroxyimino)acetate or N-hydroxybenzotriazole, and uronium salts such as HATU or HBTU in the presence of N,N-diisopropylethylamine. Because both residues are glycine, the activated species has no chiral centre adjacent to the carbonyl; the risk of stereochemical erosion is therefore negligible relative to hindered or β-branched amino acids. The principal side reaction is N-acyl urea rearrangement when carbodiimide activation is prolonged in the absence of an auxiliary nucleophile, so the auxiliary is routinely pre-dissolved before adding the carboxyl component. After coupling, the mixture is diluted with ethyl acetate, extracted with aqueous citric acid or 0.5 M hydrochloric acid, washed with sodium bicarbonate and brine, dried over sodium sulfate, and concentrated under reduced pressure at a bath temperature not exceeding 35 °C to avoid premature Boc cleavage. Reaction progress is monitored by TLC using silica gel GF254 plates and by LC-MS; published data for exact coupling rate constants under all solvent combinations is limited, and process developers generally rely on reaction monitoring rather than fixed time pauses.

For solid-phase routes, Boc-Gly-Gly-OH is coupled to aminomethyl or MBHA resin using pre-activation or in situ activation. The low steric hindrance of glycine permits efficient acylation, but the free carboxyl must be activated in the presence of a base that is compatible with the resin linker; diisopropylethylamine is normally preferred over triethylamine due to lower volatility and more consistent batch addition. Residual water in resin pores can compete with the amine nucleophile, so resin swelling in anhydrous DCM or DMF is carried out before the activated species is transferred. On production-scale peptide synthesizers, recirculation of the coupling solution for 30–60 min at 20–25 °C is typical, with a second coupling cycle if ninhydrin or chloranil testing indicates incomplete acylation.

On preparative-scale batch reactors, a recurring failure mode is incomplete activation when the carboxyl component is charged as a cold slurry rather than a clear solution. Operators have observed that addition of the coupling reagent to a partially dissolved Boc-Gly-Gly-OH charge yields a lower coupling conversion and a higher N-acyl urea byproduct, because undissolved solid continues to react as the activation intermediate decomposes. To address this, the dipeptide is dissolved in the full DMF volume at 20–25 °C before cooling to 0–4 °C, and the coupling reagent is added as a pre-cooled solution. This sequence, rather than simultaneous charging, improves batch-to-batch consistency on scale. The free carboxyl of Boc-Gly-Gly-OH also permits the preparation of stable N-hydroxysuccinimide or pentafluorophenyl esters when isolated active esters are required; these derivatives can be purified by precipitation but are moisture-sensitive and should be stored desiccated at -20 °C if not used immediately.

When Boc-Gly-Gly-OH Is Selected for Acid-Labile Solid-Phase or Solution-Phase Routes

Under acidolytic deprotection conditions, the Boc group is removed from Boc-Gly-Gly-OH or its coupled peptide with dilute to concentrated trifluoroacetic acid in dichloromethane. Typical solution-phase cleavage mixtures range from 20% to 50% v/v TFA in DCM, with water or triisopropylsilane added at 2.5–5.0% v/v to trap the tert-butyl cation and prevent reattachment. Reaction times are temperature-dependent: at 0 °C, full deprotection of a terminal Boc-glycylglycine amide may require 2–3 h, while at 25 °C the same conversion is commonly observed within 30–60 min. However, extended exposure to TFA can promote acidolysis of the glycylglycine amide bond under forcing conditions, so the deprotection should be monitored by LC-MS or TLC rather than allowed to run to a fixed overnight endpoint. After deprotection, the volatile acids are removed by rotary evaporation below 30 °C, and the crude amine is precipitated with cold diethyl ether or methyl tert-butyl ether. In solid-phase synthesis, the same TFA/DCM cocktails are used to release the peptide from the resin and remove the Boc group simultaneously; for peptides containing acid-stable side chains only, this single acid step shortens the deprotection and cleavage sequence. Conversely, when acid-labile side-chain groups such as tert-butyl esters, trityl amides, or Boc lysine are present, Boc-Gly-Gly-OH must be used only as a terminal or side-chain segment if its final deprotection is intended to be concurrent, because the conditions are not orthogonal. Operating boundaries include exclusion of water from the coupling stage, avoidance of prolonged heating above 35 °C in the presence of residual acid, and avoidance of amine-based additives during storage, as free amines can initiate premature N-terminal deprotection or salt formation with the free carboxyl.